133 related articles for article (PubMed ID: 31075260)
1. Wnt pathway markers in molecular subgroups of glioblastoma.
Tompa M; Nagy A; Komoly S; Kalman B
Brain Res; 2019 Sep; 1718():114-125. PubMed ID: 31075260
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation and protein expression of Wnt pathway markers in progressive glioblastoma.
Tompa M; Kajtar B; Galik B; Gyenesei A; Kalman B
Pathol Res Pract; 2021 Jun; 222():153429. PubMed ID: 33857857
[TBL] [Abstract][Full Text] [Related]
3. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
4. GBM-Derived Wnt3a Induces M2-Like Phenotype in Microglial Cells Through Wnt/β-Catenin Signaling.
Matias D; Dubois LG; Pontes B; Rosário L; Ferrer VP; Balça-Silva J; Fonseca ACC; Macharia LW; Romão L; E Spohr TCLS; Chimelli L; Filho PN; Lopes MC; Abreu JG; Lima FRS; Moura-Neto V
Mol Neurobiol; 2019 Feb; 56(2):1517-1530. PubMed ID: 29948952
[TBL] [Abstract][Full Text] [Related]
5. WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1.
Vassallo I; Zinn P; Lai M; Rajakannu P; Hamou MF; Hegi ME
Oncogene; 2016 Jan; 35(1):12-21. PubMed ID: 25772239
[TBL] [Abstract][Full Text] [Related]
6. Wnt5a, Ryk and Ror2 expression in glioblastoma subgroups.
Kim Y; Hong M; Do IG; Ha SY; Lee D; Suh YL
Pathol Res Pract; 2015 Dec; 211(12):963-72. PubMed ID: 26596412
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the Wnt Pathway to Defining Biology of Glioblastoma.
Tompa M; Kalovits F; Nagy A; Kalman B
Neuromolecular Med; 2018 Dec; 20(4):437-451. PubMed ID: 30259273
[TBL] [Abstract][Full Text] [Related]
8. Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma.
Kaur N; Chettiar S; Rathod S; Rath P; Muzumdar D; Shaikh ML; Shiras A
Mol Cell Neurosci; 2013 May; 54():44-57. PubMed ID: 23337036
[TBL] [Abstract][Full Text] [Related]
9. Wnt pathway markers in low-grade and high-grade gliomas.
Nagy Á; Tompa M; Krabóth Z; Garzuly F; Maráczi A; Kálmán B
Ideggyogy Sz; 2021 Sep; 74(9-10):349-355. PubMed ID: 34657400
[TBL] [Abstract][Full Text] [Related]
10. R132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signaling.
Cui D; Ren J; Shi J; Feng L; Wang K; Zeng T; Jin Y; Gao L
Int J Biochem Cell Biol; 2016 Apr; 73():72-81. PubMed ID: 26860959
[TBL] [Abstract][Full Text] [Related]
11. Role of Wnt5a in the proliferation of human glioblastoma cells.
Yu JM; Jun ES; Jung JS; Suh SY; Han JY; Kim JY; Kim KW; Jung JS
Cancer Lett; 2007 Nov; 257(2):172-81. PubMed ID: 17709179
[TBL] [Abstract][Full Text] [Related]
12. Src and Fyn define a new signaling cascade activated by canonical and non-canonical Wnt ligands and required for gene transcription and cell invasion.
Villarroel A; Del Valle-Pérez B; Fuertes G; Curto J; Ontiveros N; Garcia de Herreros A; Duñach M
Cell Mol Life Sci; 2020 Mar; 77(5):919-935. PubMed ID: 31312879
[TBL] [Abstract][Full Text] [Related]
13. Proteins of Wnt signaling pathway in cancer stem cells of human glioblastoma.
Shevchenko V; Arnotskaya N; Zaitsev S; Sharma A; Sharma HS; Bryukhovetskiy A; Pak O; Khotimchenko Y; Bryukhovetskiy I
Int Rev Neurobiol; 2020; 151():185-200. PubMed ID: 32448607
[TBL] [Abstract][Full Text] [Related]
14. Wnt5a mediated canonical Wnt signaling pathway activation in orthodontic tooth movement: possible role in the tension force-induced bone formation.
Fu HD; Wang BK; Wan ZQ; Lin H; Chang ML; Han GL
J Mol Histol; 2016 Oct; 47(5):455-66. PubMed ID: 27456852
[TBL] [Abstract][Full Text] [Related]
15. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.
Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I
Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699
[TBL] [Abstract][Full Text] [Related]
16. GOLM1 silencing inhibits the proliferation and motility of human glioblastoma cells via the Wnt/β-catenin signaling pathway.
Ding X; Deng G; Liu J; Liu B; Yuan F; Yang X; Chen Q
Brain Res; 2019 Aug; 1717():117-126. PubMed ID: 30935831
[TBL] [Abstract][Full Text] [Related]
17. Wnt5a and Wnt11 inhibit the canonical Wnt pathway and promote cardiac progenitor development via the Caspase-dependent degradation of AKT.
Bisson JA; Mills B; Paul Helt JC; Zwaka TP; Cohen ED
Dev Biol; 2015 Feb; 398(1):80-96. PubMed ID: 25482987
[TBL] [Abstract][Full Text] [Related]
18. WNT/β-catenin Signaling Pathway and Downstream Modulators in Low- and High-grade Glioma.
Denysenko T; Annovazzi L; Cassoni P; Melcarne A; Mellai M; Schiffer D
Cancer Genomics Proteomics; 2016; 13(1):31-45. PubMed ID: 26708597
[TBL] [Abstract][Full Text] [Related]
19. Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition.
Kahlert UD; Maciaczyk D; Doostkam S; Orr BA; Simons B; Bogiel T; Reithmeier T; Prinz M; Schubert J; Niedermann G; Brabletz T; Eberhart CG; Nikkhah G; Maciaczyk J
Cancer Lett; 2012 Dec; 325(1):42-53. PubMed ID: 22652173
[TBL] [Abstract][Full Text] [Related]
20. A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis.
Gonçalves CS; Xavier-Magalhães A; Martins EP; Pinto AA; Pires MM; Pinheiro C; Reis RM; Sousa N; Costa BM
Mol Oncol; 2020 Jun; 14(6):1224-1241. PubMed ID: 31923345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
